Fundies.
English

Segment disclosures

Company overview

듀켐바이오

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 17 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3011196128404 KRW20260814Open filing evidence
2026-01-01 – 2026-06-3020900756992 KRW20260814Open filing evidence
2026-01-01 – 2026-03-319704628588 KRW20260514Open filing evidence
2025-01-01 – 2025-12-3138572364091 KRW20260318Open filing evidence
2025-07-01 – 2025-09-309925071939 KRW20251113Open filing evidence
2025-01-01 – 2025-09-3027889001698 KRW20251113Open filing evidence
2025-04-01 – 2025-06-309504526393 KRW20260814Open filing evidence
2025-01-01 – 2025-06-3017963929759 KRW20260814Open filing evidence
2025-01-01 – 2025-03-318459403366 KRW20260514Open filing evidence
2024-01-01 – 2024-12-3135600990962 KRW20260318Open filing evidence
2024-07-01 – 2024-09-308494776393 KRW20251113Open filing evidence
2024-01-01 – 2024-09-3026244798355 KRW20251113Open filing evidence
2024-04-01 – 2024-06-309345178673 KRW20250814Open filing evidence
2024-01-01 – 2024-06-3017750021962 KRW20250814Open filing evidence
2024-01-01 – 2024-03-318404843289 KRW20250515Open filing evidence
2023-01-01 – 2023-12-3134695489500 KRW20260318Open filing evidence
2022-01-01 – 2022-12-3132422307386 KRW20250321Open filing evidence